Related Experiment Video
Updated: Jun 8, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
[Hereditary breast and ovarian cancers]
H Gevensleben1, N Serçe, R Büttner
1Institut für Pathologie, Universitätsklinikum Bonn, Sigmund-Freud-Straße 25, 53127, Bonn. heidrun.gevensleben@ukb.uni-bonn.de
Hereditary breast and ovarian cancer risk is linked to BRCA1/BRCA2 gene mutations. Early detection and genetic testing are crucial for high-risk families, guiding targeted therapies like PARP inhibitors.
Area of Science:
- Oncology
- Genetics
- Cancer Research
Context:
- Hereditary factors contribute to 5-10% of breast cancers and 10% of ovarian cancers.
- Mutations in BRCA1 and BRCA2 are the primary cause of hereditary breast and ovarian cancer.
- Ongoing research analyzes moderate and low penetrance gene variants through whole genome association studies.
Purpose:
- To highlight the significance of hereditary factors in breast and ovarian cancers.
- To emphasize the clinical importance of identifying BRCA-deficient carcinomas for novel therapeutic strategies.
- To underscore the need for specialized care, including genetic counseling and testing, for high-risk families.
Summary:
- Hereditary factors, mainly BRCA1/BRCA2 mutations, significantly increase breast and ovarian cancer risk.
- Specialized medical centers provide essential genetic counseling, testing, and prevention for high-risk families.
- BRCA-deficient tumors are of clinical interest for targeted treatments like poly (ADP-ribose) polymerase (PARP) inhibitors.
Impact:
- Improved identification and management of individuals and families with hereditary cancer predispositions.
- Advancement in personalized medicine through the development of targeted therapies for BRCA-mutated cancers.
- Enhanced understanding of the specific histopathological features associated with BRCA1 mutations in breast cancer.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Cancer Prevention
Some...